InSilico Medicine’s $35 Million Series D2 Financing

Davis Polk advised InSilico Medicine in the transaction.InSilico Medicine completed its $35 million Series D2 financing, bringing the total Series D financing to $95 million. The…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now